training, and therefore common aging-related conditions that influence outcomes are rarely detected. 13 – 16 In this study, community oncologists were recruited to participate in 2 nationwide, geriatric oncology clinical trials in the University of
Search Results
Supriya G. Mohile, Allison Magnuson, Chintan Pandya, Carla Velarde, Paul Duberstein, Arti Hurria, Kah Poh Loh, Megan Wells, Sandy Plumb, Nikesha Gilmore, Marie Flannery, Marsha Wittink, Ronald Epstein, Charles E. Heckler, Michelle Janelsins, Karen Mustian, Judith O. Hopkins, Jane Liu, Srihari Peri, and William Dale
Elizabeth R. Kessler, Janet B. Kukreja, Christopher L. Geiger, and Stacy M. Fischer
include treatment planning from multiple disciplines, such as surgical urologic oncology, medical oncology, and radiation oncology. As clinicians develop treatment plans, considering a geriatric oncology perspective may enhance patient care and influence
June M. McKoy, Peggy S. Burhenn, Ilene S. Browner, Kari L. Loeser, Katrina M. Tulas, Megan R. Oden, and Randall W. Rupper
should therefore be incorporated into the clinical plan of care. The Comprehensive Geriatric Assessment (CGA) is one such tool that can be recruited within the geriatric oncology domain to assess functional status (cognitive and physical), nutritional
Tammy T. Hshieh, Clark DuMontier, Timothy Jaung, Nupur E. Bahl, Chelsea E. Hawley, Lee Mozessohn, Richard M. Stone, Robert J. Soiffer, Jane A. Driver, and Gregory A. Abel
oncologists and geriatricians to assist with the identification of medications often encountered in oncology practice that carry risks for older patients. 33 We translated the list into the Geriatric Oncology Potentially Inappropriate Medications (GO
Robert W. Carlson, Susan Moench, Arti Hurria, Lodovico Balducci, Harold J. Burstein, Lori J. Goldstein, William J. Gradishar, Kevin S. Hughes, Mohammad Jahanzeb, Stuart M. Lichtman, Lawrence B. Marks, Joan S. McClure, Beryl McCormick, Lisle M. Nabell, Lori J. Pierce, Mary Lou Smith, Neal S. Topham, Tiffany A. Traina, John H. Ward, and Eric P. Winer
older woman. A total of 18 task force members represented medical oncology, radiation oncology, surgical oncology, geriatric oncology, geriatrics, plastic surgery, and patient advocacy. All task force members were identified and invited solely by NCCN. A
Efrat Dotan and Louise C. Walter
On November 7, 2018, the NCCN Older Adult Oncology Panel and the geriatric oncology community as a whole lost a tremendous leader, mentor, and scientist with the passing of Arti Hurria, MD, in a tragic accident. As the NCCN Older Adult Panel mourns
June M. McKoy
?” That was so like Dr. Hurria: to be inclusive, enthusiastic, and generous. And that was the last correspondence we had. On November 7, 2018, Dr. Arti Hurria, George Tsai Family Chair in Geriatric Oncology, Director of the Center for Cancer and Aging at
Armin Shahrokni, Bella Marie Vishnevsky, Brian Jang, Saman Sarraf, Koshy Alexander, Soo Jung Kim, Robert Downey, Anoushka Afonso, and Beatriz Korc-Grodzicki
survival. 8 , 10 – 12 Furthermore, the ASA system is easy to use and has broad awareness and acceptance. 8 , 9 However, its use in the geriatric oncology population has been questioned. In one study of 178 patients aged ≥70 years who underwent elective
Armin Shahrokni and Manpreet K. Boparai
geriatric oncology clinic to assess medication appropriateness, polypharmacy, PIMs, and deprescribing in order to optimize medication use in this population. In other clinic settings, pharmacists have been effectively used to identify polypharmacy and PIMs
Ryan D. Nipp, Brandon Temel, Charn-Xin Fuh, Paul Kay, Sophia Landay, Daniel Lage, Esteban Franco-Garcia, Erin Scott, Erin Stevens, Terrence O’Malley, Supriya Mohile, William Dale, Lara Traeger, Ardeshir Z. Hashmi, Vicki Jackson, Joseph A. Greer, Areej El-Jawahri, and Jennifer S. Temel
symptom burden, pervasive comorbid conditions, and impaired functional status, our findings underscore the tremendous potential for efforts such as this transdisciplinary intervention to enhance care outcomes for the geriatric oncology population. This
